JP2018519370A5 - - Google Patents

Download PDF

Info

Publication number
JP2018519370A5
JP2018519370A5 JP2017557435A JP2017557435A JP2018519370A5 JP 2018519370 A5 JP2018519370 A5 JP 2018519370A5 JP 2017557435 A JP2017557435 A JP 2017557435A JP 2017557435 A JP2017557435 A JP 2017557435A JP 2018519370 A5 JP2018519370 A5 JP 2018519370A5
Authority
JP
Japan
Prior art keywords
aspects
vesicle
buffer
mosm
osmotic pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017557435A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018519370A (ja
JP6715265B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/059912 external-priority patent/WO2016177741A1/en
Publication of JP2018519370A publication Critical patent/JP2018519370A/ja
Publication of JP2018519370A5 publication Critical patent/JP2018519370A5/ja
Application granted granted Critical
Publication of JP6715265B2 publication Critical patent/JP6715265B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017557435A 2015-05-04 2016-05-03 膜内外pH勾配ベシクルを調製する方法 Active JP6715265B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15166247 2015-05-04
EP15166247.5 2015-05-04
PCT/EP2016/059912 WO2016177741A1 (en) 2015-05-04 2016-05-03 Method for preparing transmembrane ph-gradient vesicles

Publications (3)

Publication Number Publication Date
JP2018519370A JP2018519370A (ja) 2018-07-19
JP2018519370A5 true JP2018519370A5 (https=) 2019-01-17
JP6715265B2 JP6715265B2 (ja) 2020-07-01

Family

ID=53052718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017557435A Active JP6715265B2 (ja) 2015-05-04 2016-05-03 膜内外pH勾配ベシクルを調製する方法

Country Status (11)

Country Link
US (2) US11376218B2 (https=)
EP (1) EP3291797B1 (https=)
JP (1) JP6715265B2 (https=)
CN (1) CN107750156B (https=)
AU (1) AU2016256979B2 (https=)
DK (1) DK3291797T3 (https=)
ES (1) ES2826896T3 (https=)
MX (1) MX381655B (https=)
PT (1) PT3291797T (https=)
RU (1) RU2717824C2 (https=)
WO (1) WO2016177741A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016256979B2 (en) * 2015-05-04 2021-01-28 Genfit Method for preparing transmembrane pH-gradient vesicles
KR20230110284A (ko) 2020-11-17 2023-07-21 장피트 간부전 치료 방법
EP4618954A1 (en) 2022-11-16 2025-09-24 Genfit Use of transmembrane ph gradient liposomes for treating hyperammonemic crisis associated with inborn errors of metabolism
WO2026078189A1 (en) 2024-10-11 2026-04-16 Genfit Treating endotoxemia with a liposomal suspension
WO2026078188A1 (en) 2024-10-11 2026-04-16 Genfit Reducing a pathological blood level of bile acids with a liposome suspension

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5297024A (en) 1976-02-09 1977-08-15 Nissan Motor Co Ltd Air fuel ratio controller
FR2521565B1 (fr) 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
FR2553002B1 (fr) 1983-10-06 1992-03-27 Centre Nat Rech Scient Procede perfectionne d'obtention de liposomes unilamellaires de diametres eleves, leur application pharmacologique pour l'encapsulage d'un principe actif en vue de son administration extemporanee et dispositif correspondant
US4532089A (en) 1984-01-14 1985-07-30 Northwestern University Method of preparing giant size liposomes
US5077056A (en) 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5230899A (en) * 1985-08-07 1993-07-27 Smithkline Beecham Corporation Methods and compositions for making liposomes
US5622713A (en) 1985-09-17 1997-04-22 The Regents Of The University Of California Method of detoxifying animal suffering from overdose
DE3765711D1 (de) 1986-07-15 1990-11-29 Fin Omet S R L Methode zum herstellen von handtuechern fuer spender sowie auf diese weise hergestellte handtuecher und dazugehoeriger behaelter.
WO1988001864A1 (en) 1986-09-18 1988-03-24 Liposome Technology, Inc. High-concentration liposome processing method
JPS63211222A (ja) 1987-02-27 1988-09-02 Terumo Corp リポソ−ムの製法
JPH03501732A (ja) 1987-12-22 1991-04-18 ザ リポソーム カンパニー,インコーポレイテッド 多重ラメラリポソームの自発的小胞化方法
US5807572A (en) 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
DE68901733T2 (de) 1988-03-04 1993-03-25 Takeda Chemical Industries Ltd Liposom-zusammensetzung.
WO1990003808A1 (en) 1988-10-07 1990-04-19 The Liposome Company, Inc. Heat treating liposomes
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
US5185154A (en) 1989-02-02 1993-02-09 Liposome Technology, Inc. Method for instant preparation of a drug containing large unilamellar vesicles
DE3913875C1 (https=) 1989-04-27 1990-08-09 Heraeus Quarzschmelze Gmbh, 6450 Hanau, De
EP0472639A4 (en) 1989-05-15 1992-07-01 The Liposome Company, Inc. Accumulation of drugs into liposomes by a proton gradient
JP2880800B2 (ja) 1989-06-22 1999-04-12 ネクスター・フアーマシユーテイカルズ・インコーポレイテツド カプセル化方法
US5039305A (en) 1989-12-18 1991-08-13 Ford Motor Company Multiple ratio compact transaxle assembly for automotive vehicles
US5773024A (en) 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
JP3228957B2 (ja) 1990-06-14 2001-11-12 キヤノン株式会社 巨大リポソームの製造方法及び巨大リポソーム形成用キット
IS1685B (is) 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5327038A (en) 1991-05-09 1994-07-05 Rockwell International Corporation Walking expansion actuator
CA2093381A1 (en) 1992-04-07 1993-10-08 Hideyuki Sawahara Liposome formulation and process for production thereof
JPH06710A (ja) 1992-06-17 1994-01-11 Toshimasu Eguchi 工作機械及びその加工方法
JPH069710A (ja) 1992-06-25 1994-01-18 Canon Inc 巨大リポソームの調製方法、lb膜製造装置及び該装置を用いたlb膜の製造方法
US5766627A (en) 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
WO1996032930A1 (en) 1995-04-18 1996-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
US5686309A (en) * 1996-01-19 1997-11-11 Coulter International Corp. Method and apparatus for determination of hemoglobin content of individual red blood cells
GB9605915D0 (en) 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
US20020136762A1 (en) 1998-01-14 2002-09-26 See Jackie R. Method for inducing a systemic immune response to an antigen
US6106858A (en) 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
US6306432B1 (en) 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
CA2304096C (en) 1997-09-18 2003-09-09 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
IN190388B (https=) 1997-10-01 2003-07-26 Biomira Usa Inc
CA2298475A1 (en) * 1997-10-31 1999-05-14 Walter Reed Army Institute Of Research Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
US20050031679A1 (en) 1998-03-27 2005-02-10 Clemens Unger Method for producing liposomal formulations of active ingredients
IL140892A0 (en) 1998-08-12 2002-02-10 Yissum Res Dev Co Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
HUP0202475A3 (en) 1999-07-16 2004-06-28 Alza Corp A liposome composition having resistance to freeze/thaw damage
AU2001264079A1 (en) 2000-06-14 2001-12-24 William Leslie Porter Lipids for modulating immune response
AR031744A1 (es) 2001-11-08 2003-10-01 Paoli Tomas De Proliposomas en polvo, un procedimiento para la elaboracion de dichas proliposomas en polvo, procedimiento para la preparacion de una composicion farmaceutica empleando proliposomas en polvo y aparato para ser empleado en el procedimiento de elaboracion de dichas proliposomas en polvo
AU2002340670A1 (en) * 2001-11-13 2003-05-26 Celator Technologies, Inc. Lipid carrier compositions and methods for improved drug retention
JP2005530704A (ja) 2002-03-05 2005-10-13 トランセイブ, インク. 細胞内感染を予防及び治療するための吸入システム
GB0312309D0 (en) * 2003-05-29 2003-07-02 Gaslini Children S Hospital G Targeted liposome
CN101889981A (zh) * 2003-11-20 2010-11-24 Ym生物科学有限公司 包含含有药物成分的亲脂胺的稳定脂质体组合物
EP1547580A1 (en) 2003-12-23 2005-06-29 MediGene Oncology GmbH Loading of a camptothecin drug into colloidal nanoparticles
EP2407169A1 (en) 2004-04-22 2012-01-18 Celator Pharmaceuticals, Inc. Combination formulations of anthracycline agents and cytidine analogs
EP1776948B1 (en) * 2004-08-11 2015-12-09 Konica Minolta Medical & Graphic, Inc. Method of producing liposome-containing preparation
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds
US20060239925A1 (en) * 2005-04-21 2006-10-26 Konica Minolta Medical & Graphic, Inc. Method of manufacturing pharmaceutical preparation containing liposomes
ES2275443B1 (es) 2005-11-30 2008-06-01 Italfarmaco, S.A. Procedimiento de preparacion de liposomas.
JP5484059B2 (ja) 2006-10-06 2014-05-07 エスシーアイエル テクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング 脊髄核インプラント
US8071127B2 (en) * 2006-10-24 2011-12-06 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
JP5080779B2 (ja) * 2006-10-25 2012-11-21 テルモ株式会社 リポソーム製剤の製造方法
JP2008136967A (ja) 2006-12-04 2008-06-19 Shinshu Univ リポソームおよびその製造方法
US20090017108A1 (en) 2007-07-11 2009-01-15 Alexander Yuzhakov Liposome compositions for treatment of hepatitis C
CA2697044A1 (en) * 2007-08-21 2009-02-26 Alza Corporation Liposome formulations of boronic acid compounds
WO2009091531A2 (en) 2008-01-16 2009-07-23 The General Hospital Corporation Uniform-sized, multi-drug carrying and photosensitive liposomes for advance drug delivery
EP2253308A1 (en) 2009-05-22 2010-11-24 Ludwig-Maximilians-Universität München Pharmaceutical composition comprising microbubbles for targeted tumor therapy
WO2010138918A1 (en) 2009-05-29 2010-12-02 Pacira Pharmaceuticals, Inc. Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
JP5771366B2 (ja) 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
CA2781527C (en) 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
US20110250264A1 (en) 2010-04-09 2011-10-13 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
EP2394640A1 (en) 2010-05-21 2011-12-14 MediGene AG Improved liposomal formulations of lipophilic compounds
EP2433619A1 (en) 2010-09-24 2012-03-28 Intsel Chimos Novel antitumoral agent and its therapeutic uses
JP5947807B2 (ja) * 2010-12-14 2016-07-06 テクニカル ユニバーシティ オブ デンマークTechnical University Of Denmark ナノ粒子組成物への放射性核種の封入
TR201911076T4 (tr) * 2011-01-05 2019-08-21 Prenatal Int Gmbh Klorür içeriği azaltılmış fosfolipit içeren veya içermeyen hipotonik sulu bileşim.
JP2012158576A (ja) 2011-02-03 2012-08-23 Yuki Goto 高圧力を利用したリポソームの粒子径制御方法
US8871811B2 (en) 2011-02-07 2014-10-28 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
JP2014101273A (ja) 2011-02-28 2014-06-05 Tokyo Medical And Dental Univ 脂質構造体の製造方法
RU2014133467A (ru) * 2012-02-17 2016-04-10 Селшн Корпорейшн Термочувствительные составы в виде наночастиц и способ их получения
CN102626390B (zh) 2012-04-19 2013-05-29 海南灵康制药有限公司 一种天麻素多相脂质体注射液
CN102716089B (zh) 2012-06-29 2013-12-11 海南灵康制药有限公司 一种盐酸吉西他滨脂质体注射剂
GB201212896D0 (en) 2012-07-20 2012-09-05 European Molecular Biology Lab Embl Giant array liposome for high-throughput lipid-protein interaction screening
EP2695606A1 (en) 2012-08-09 2014-02-12 ETH Zürich Liposome composition for peritoneal dialysis
RU2516893C1 (ru) * 2012-12-14 2014-05-20 Общество с ограниченной ответственностью "Уральский центр биофармацевтических технологий" Липосомальная композиция и способ ее получения
WO2014116866A1 (en) 2013-01-24 2014-07-31 Memorial Sloan Kettering Cancer Center Method for diagnosing or treating tumors using sphingomyelin containing liposomes
CN103182333B (zh) 2013-03-01 2015-07-29 重庆大学 一种脂质体制备和收集装置及方法
AU2016256979B2 (en) * 2015-05-04 2021-01-28 Genfit Method for preparing transmembrane pH-gradient vesicles

Similar Documents

Publication Publication Date Title
JP2018519370A5 (https=)
JP2017093436A5 (https=)
JP2018500343A5 (https=)
JP2013501100A5 (https=)
JP2013537518A5 (https=)
JP2008519673A5 (ja) 複合半透膜、およびその製造方法
KR101998537B1 (ko) 바이러스 정제를 위한 연속 초원심분리용 당 용액의 제조
JP2014520852A5 (https=)
JP2013539483A5 (https=)
JP2012532200A5 (https=)
JP2013535549A5 (https=)
RU2017141919A (ru) Способ получения пузырьков с трансмембранным градиентом рн
RU2017101833A (ru) Орально распадающийся пленочный препарат, содержащий тадалафил, и способ его приготовления
JP2013532677A5 (https=)
JP2012066088A5 (https=)
JP2017507895A5 (https=)
BR112017004746A2 (pt) métodos para preparação de virossomas adjuvados, para otimizar a proporção adjuvante/antígeno de uma vacina à base de virossoma e para imunizar um indivíduo contra uma doença, virossoma adjuvado, composição farmacêutica, e, composição imunogênica.
RU2019127181A (ru) Способы и системы для улучшения стабильности предиспарительных составов е-вейпинговых устройств
FI3541362T3 (fi) Triptaania käsittävä alginaattikalvo
JP2015527125A5 (https=)
RU2005140291A (ru) Способ получения содержащих альгинат пористых формованных изделий
BRPI0416650A (pt) composição de lipossoma estável para a aplicação de um agente farmacêutico, composição de lipossoma estéril e estável para a aplicação de um agente farmacêutico método para a produção de uma composição de lipossoma estável para a aplicação de um agente farmacêutico, composição farmacêutica, uso de uma composição de lipossoma, dispositivo para conter uma composição de lipossoma estável, kit para a aplicação de um agente farmacêutico a um paciente, método para aumentar a estabilidade de composições de lipossomas, método para a identificação de uma composição de lipossoma estável na fase, composição de lipossoma e composição de lipossoma estável na fase
FI3600435T3 (fi) Hydrofilisten yhdisteiden korkean tehokas kapselointi unilamellaarisiin liposomeihin
Porte et al. A molecular view of lipid nanoparticles: insights into their morphology and structural plasticity
EA201070780A1 (ru) Активный фармацевтический ингредиент на твердом аморфном носителе и с повышенной растворимостью